374 related articles for article (PubMed ID: 27141418)
1. Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking.
Pandey PK; Sharma AK; Gupta U
Tissue Barriers; 2016; 4(1):e1129476. PubMed ID: 27141418
[TBL] [Abstract][Full Text] [Related]
2. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.
Greene C; Campbell M
Tissue Barriers; 2016; 4(1):e1138017. PubMed ID: 27141420
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle transport across the blood brain barrier.
Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426
[TBL] [Abstract][Full Text] [Related]
4. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.
Song J; Lu C; Leszek J; Zhang J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576281
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
6. Nano carriers for drug transport across the blood-brain barrier.
Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
[TBL] [Abstract][Full Text] [Related]
7. A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport.
Wevers NR; Kasi DG; Gray T; Wilschut KJ; Smith B; van Vught R; Shimizu F; Sano Y; Kanda T; Marsh G; Trietsch SJ; Vulto P; Lanz HL; Obermeier B
Fluids Barriers CNS; 2018 Aug; 15(1):23. PubMed ID: 30165870
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in delivery through the blood-brain barrier.
Larsen JM; Martin DR; Byrne ME
Curr Top Med Chem; 2014; 14(9):1148-60. PubMed ID: 24678707
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood-brain barrier (BBB) to manage neurological disorders.
Correia AC; Monteiro AR; Silva R; Moreira JN; Sousa Lobo JM; Silva AC
Adv Drug Deliv Rev; 2022 Oct; 189():114485. PubMed ID: 35970274
[TBL] [Abstract][Full Text] [Related]
10. Targeted brain derived neurotropic factors (BDNF) delivery across the blood-brain barrier for neuro-protection using magnetic nano carriers: an in-vitro study.
Pilakka-Kanthikeel S; Atluri VS; Sagar V; Saxena SK; Nair M
PLoS One; 2013; 8(4):e62241. PubMed ID: 23653680
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnologies: a strategy to overcome blood-brain barrier.
De Rosa G; Salzano G; Caraglia M; Abbruzzese A
Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
[TBL] [Abstract][Full Text] [Related]
12. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
13. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia.
Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP
J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Human Blood-Brain Barrier Model for Drug Permeability Testing.
Bayir E; Sendemir A
Methods Mol Biol; 2021; 2367():73-85. PubMed ID: 33686632
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
16. The role of non-endothelial cells on the penetration of nanoparticles through the blood brain barrier.
Moura RP; Almeida A; Sarmento B
Prog Neurobiol; 2017 Dec; 159():39-49. PubMed ID: 28899762
[TBL] [Abstract][Full Text] [Related]
17. Crossing the blood-brain barrier: Glutathione-conjugated poly(ethylene imine) for gene delivery.
Englert C; Trützschler AK; Raasch M; Bus T; Borchers P; Mosig AS; Traeger A; Schubert US
J Control Release; 2016 Nov; 241():1-14. PubMed ID: 27586188
[TBL] [Abstract][Full Text] [Related]
18. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles.
Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA
Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790
[TBL] [Abstract][Full Text] [Related]
19. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
20. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]